ClinVar Miner

Submissions for variant NM_000546.6(TP53):c.1005_1010del (p.Glu336_Arg337del)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV003177170 SCV003856755 pathogenic Hereditary cancer-predisposing syndrome 2022-11-22 criteria provided, single submitter clinical testing The c.1005_1010delTGAGCG pathogenic mutation (also known as p.E336_R337del) is located in coding exon 9 of the TP53 gene. This pathogenic mutation results from an in-frame TGAGCG deletion at nucleotide positions 1005 to 1010. This results in the in-frame deletion of the glutamic acid and arginine residues at codons 336-337. This alteration has been observed in at least one individual with a personal and/or family history meeting Chompret criteria (Ambry internal data). This amino acid region is not well conserved in available vertebrate species and the impacted region is critical for protein function (Ambry internal data). In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.